Sort   by:  
 Page size 
UnknownEffects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis.
Not available
S-EPMC9822869 | biostudies-literature
UnknownMultiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses.
Not available
S-EPMC10092421 | biostudies-literature
UnknownDenosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review.
Not available
S-EPMC8799550 | biostudies-literature
UnknownComparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.
Not available
S-EPMC9499892 | biostudies-literature
UnknownCardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.
Not available
S-EPMC7500469 | biostudies-literature
UnknownRomosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.
Not available
S-EPMC11371899 | biostudies-literature
UnknownComparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.
Not available
S-EPMC10463267 | biostudies-literature
UnknownCorrection to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Not available
S-EPMC7360655 | biostudies-literature
UnknownBiomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis.
Not available
S-EPMC7237403 | biostudies-literature
UnknownAbaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Not available
S-EPMC6546661 | biostudies-literature
Sort   by:  
 Page size